153 related articles for article (PubMed ID: 11864784)
21. A critical investigation of NADPH oxidase activity in human spermatozoa.
Richer SC; Ford WC
Mol Hum Reprod; 2001 Mar; 7(3):237-44. PubMed ID: 11228243
[TBL] [Abstract][Full Text] [Related]
22. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C.
Heitzer T; Wenzel U; Hink U; Krollner D; Skatchkov M; Stahl RA; MacHarzina R; Bräsen JH; Meinertz T; Münzel T
Kidney Int; 1999 Jan; 55(1):252-60. PubMed ID: 9893134
[TBL] [Abstract][Full Text] [Related]
23. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control.
Souza HP; Laurindo FR; Ziegelstein RC; Berlowitz CO; Zweier JL
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H658-67. PubMed ID: 11158964
[TBL] [Abstract][Full Text] [Related]
24. Detergent-amplified chemiluminescence of lucigenin for determination of superoxide anion production by NADPH oxidase and xanthine oxidase.
Storch J; Ferber E
Anal Biochem; 1988 Mar; 169(2):262-7. PubMed ID: 2837920
[TBL] [Abstract][Full Text] [Related]
25. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system.
Warnholtz A; Nickenig G; Schulz E; Macharzina R; Bräsen JH; Skatchkov M; Heitzer T; Stasch JP; Griendling KK; Harrison DG; Böhm M; Meinertz T; Münzel T
Circulation; 1999 Apr; 99(15):2027-33. PubMed ID: 10209008
[TBL] [Abstract][Full Text] [Related]
26. Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes.
Minkenberg I; Ferber E
J Immunol Methods; 1984 Jun; 71(1):61-7. PubMed ID: 6725961
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway.
Janiszewski M; Do Carmo AO; Pedro MA; Silva E; Knobel E; Laurindo FR
Crit Care Med; 2004 Mar; 32(3):818-25. PubMed ID: 15090968
[TBL] [Abstract][Full Text] [Related]
28. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
[TBL] [Abstract][Full Text] [Related]
29. Quantification of superoxide radical formation in intact vascular tissue using a Cypridina luciferin analog as an alternative to lucigenin.
Skatchkov MP; Sperling D; Hink U; Anggard E; Münzel T
Biochem Biophys Res Commun; 1998 Jul; 248(2):382-6. PubMed ID: 9675145
[TBL] [Abstract][Full Text] [Related]
30. Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study.
Vásquez-Vivar J; Hogg N; Pritchard KA; Martasek P; Kalyanaraman B
FEBS Lett; 1997 Feb; 403(2):127-30. PubMed ID: 9042951
[TBL] [Abstract][Full Text] [Related]
31. Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.
Schuijt MP; Tom B; de Vries R; Saxena PR; Sluiter W; van Kats JP; Danser AH
J Hypertens; 2003 Dec; 21(12):2335-44. PubMed ID: 14654755
[TBL] [Abstract][Full Text] [Related]
32. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle.
Mohazzab KM; Wolin MS
Am J Physiol; 1994 Dec; 267(6 Pt 1):L815-22. PubMed ID: 7810685
[TBL] [Abstract][Full Text] [Related]
33. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production.
Skatchkov MP; Sperling D; Hink U; Mülsch A; Harrison DG; Sindermann I; Meinertz T; Münzel T
Biochem Biophys Res Commun; 1999 Jan; 254(2):319-24. PubMed ID: 9918836
[TBL] [Abstract][Full Text] [Related]
34. An NADPH oxidase superoxide-generating system in the rabbit aorta.
Pagano PJ; Ito Y; Tornheim K; Gallop PM; Tauber AI; Cohen RA
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2274-80. PubMed ID: 7611477
[TBL] [Abstract][Full Text] [Related]
35. Cell-surface NAD(P)H-oxidase: relationship to trans-plasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase.
Berridge MV; Tan AS
Antioxid Redox Signal; 2000; 2(2):277-88. PubMed ID: 11229532
[TBL] [Abstract][Full Text] [Related]
36. Osteoclast radical interactions: NADPH causes pulsatile release of NO and stimulates superoxide production.
Silverton SF; Mesaros S; Markham GD; Malinski T
Endocrinology; 1995 Nov; 136(11):5244-7. PubMed ID: 7588266
[TBL] [Abstract][Full Text] [Related]
37. Lucigenin is a mediator of cytochrome C reduction but not of superoxide production.
Afanas'ev IB; Ostrachovitch EA; Korkina LG
Arch Biochem Biophys; 1999 Jun; 366(2):267-74. PubMed ID: 10356292
[TBL] [Abstract][Full Text] [Related]
38. Lucigenin chemiluminescence in human seminal plasma.
Ochsendorf FR; Goy C; Fuchs J; Mörke W; Beschmann HA; Brömme HJ
Free Radic Res; 2001 Feb; 34(2):153-65. PubMed ID: 11264892
[TBL] [Abstract][Full Text] [Related]
39. Increased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment.
Rashba-Step J; Turro NJ; Cederbaum AI
Arch Biochem Biophys; 1993 Jan; 300(1):401-8. PubMed ID: 8380969
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of the redox-cycling of a quinone (rifamycin S) and a quinonimine (rifabutin) antibiotic by rat liver microsomes.
Rao DN; Cederbaum AI
Free Radic Biol Med; 1997; 22(3):439-46. PubMed ID: 8981035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
